The FDA has designated a recall of various Impella Left-Sided Blood Pumps from Abiomed, Inc. as class I, its most serious.
The agency said Abiomed recalled the pumps because the instructions for use (IFU) do not adequately address the precautions clinicians need to take when treating patients who have undergone transcatheter...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?